Parvoviruses as cancer therapeutics

被引：0
|
作者：
Rommelaere, Jean [1 ]
机构：
[1] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
来源：
HUMAN GENE THERAPY | 2009年 / 20卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1353 / 1353
页数：1
相关论文
共 50 条
  • [21] Cancer therapeutics in yeast
    Bjornsti, MA
    CANCER CELL, 2002, 2 (04) : 267 - 273
  • [22] Immunomodulation in cancer therapeutics
    Ehrke, MJ
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (08) : 1105 - 1119
  • [23] Biomarkers in cancer therapeutics
    LoBuglio, AF
    Pluda, J
    Ivy, P
    BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 233 - 254
  • [24] Targeted Cancer Therapeutics
    Hait, William N.
    CANCER RESEARCH, 2009, 69 (04) : 1263 - 1267
  • [25] Telomerase and cancer therapeutics
    Calvin B. Harley
    Nature Reviews Cancer, 2008, 8 : 167 - 179
  • [26] Telomerase and cancer therapeutics
    Harley, Calvin B.
    NATURE REVIEWS CANCER, 2008, 8 (03) : 167 - 179
  • [27] Antibody Therapeutics in Cancer
    Sliwkowski, Mark X.
    Mellman, Ira
    SCIENCE, 2013, 341 (6151) : 1192 - 1198
  • [28] MicroRNAs and Cancer Therapeutics
    Man Lung Yeung
    Kuan-Teh Jeang
    Pharmaceutical Research, 2011, 28 : 3043 - 3049
  • [29] IMMUNOSUPPRESSION IN CANCER THERAPEUTICS
    MIHICH, E
    TRANSPLANTATION PROCEEDINGS, 1975, 7 (02) : 275 - 278
  • [30] Advances in Cancer Therapeutics
    Dang, Shweta
    Baboota, Sanjula
    Ali, Javed
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (45) : 4513 - 4514
12345